| Primary |
| Local Anaesthesia |
19.2% |
| Dyspepsia |
11.0% |
| Nerve Block |
11.0% |
| Gastrooesophageal Reflux Disease |
9.6% |
| Product Used For Unknown Indication |
9.6% |
| Anaesthesia |
8.2% |
| Abdominal Discomfort |
4.1% |
| Analgesic Therapy |
4.1% |
| Dysmenorrhoea |
4.1% |
| Atrial Fibrillation |
2.7% |
| Diabetic Ketoacidosis |
2.7% |
| Hyperchlorhydria |
2.7% |
| Blood Potassium Increased |
1.4% |
| Cardio-respiratory Arrest |
1.4% |
| Cerumen Removal |
1.4% |
| Chronic Obstructive Pulmonary Disease |
1.4% |
| Dry Mouth |
1.4% |
| Flatulence |
1.4% |
| Heart Rate Irregular |
1.4% |
| Lesion Excision |
1.4% |
|
| Medication Error |
17.3% |
| Drug Dependence |
11.5% |
| Off Label Use |
7.7% |
| Apparent Death |
5.8% |
| Wrong Technique In Drug Usage Process |
5.8% |
| Asthenia |
3.8% |
| Choking |
3.8% |
| Coeliac Disease |
3.8% |
| Coma |
3.8% |
| Drug Toxicity |
3.8% |
| Erythema |
3.8% |
| Feeling Abnormal |
3.8% |
| Hypersensitivity |
3.8% |
| Injection Site Pain |
3.8% |
| Loss Of Consciousness |
3.8% |
| Rash |
3.8% |
| Respiratory Arrest |
3.8% |
| Abdominal Pain Upper |
1.9% |
| Blister |
1.9% |
| Bronchial Disorder |
1.9% |
|
| Secondary |
| Product Used For Unknown Indication |
31.7% |
| Drug Use For Unknown Indication |
21.0% |
| Acute Lymphocytic Leukaemia |
6.4% |
| Hypertension |
4.1% |
| Acute Leukaemia |
3.9% |
| Suicide Attempt |
3.3% |
| Diffuse Large B-cell Lymphoma |
2.8% |
| Drug Toxicity |
2.8% |
| Pain |
2.5% |
| Ph Urine Abnormal |
2.3% |
| Resuscitation |
2.3% |
| Asthma |
2.0% |
| Bleeding |
2.0% |
| Epidural Anaesthesia |
2.0% |
| Fluid Replacement |
1.9% |
| Hypotension |
1.9% |
| Non-hodgkin's Lymphoma |
1.9% |
| Haematuria |
1.7% |
| Infection |
1.7% |
| Mantle Cell Lymphoma |
1.7% |
|
| Toxic Epidermal Necrolysis |
18.3% |
| Encephalopathy |
9.6% |
| Vomiting |
9.6% |
| Completed Suicide |
7.7% |
| Tinnitus |
5.8% |
| Medication Error |
4.8% |
| Memory Impairment |
4.8% |
| Pain |
3.8% |
| Renal Failure Acute |
3.8% |
| Unresponsive To Stimuli |
3.8% |
| Ventricular Tachycardia |
3.8% |
| Death |
2.9% |
| Drug Administration Error |
2.9% |
| Fanconi Syndrome |
2.9% |
| Hypernatraemia |
2.9% |
| Rhabdomyolysis |
2.9% |
| Thrombocytopenia |
2.9% |
| Uterine Enlargement |
2.9% |
| Abdominal Pain Upper |
1.9% |
| Acidosis Hyperchloraemic |
1.9% |
|
| Concomitant |
| Product Used For Unknown Indication |
44.4% |
| Drug Use For Unknown Indication |
21.8% |
| Prophylaxis |
7.6% |
| Hypertension |
4.1% |
| Pain |
2.7% |
| Multiple Myeloma |
2.3% |
| Renal Transplant |
1.6% |
| Nausea |
1.5% |
| Coronary Artery Bypass |
1.5% |
| Renal Failure Chronic |
1.5% |
| Constipation |
1.5% |
| Premedication |
1.3% |
| Infection Prophylaxis |
1.2% |
| Diabetes Mellitus |
1.1% |
| Acute Lymphocytic Leukaemia |
1.1% |
| Bone Marrow Conditioning Regimen |
1.1% |
| Anaemia |
1.0% |
| Nuclear Magnetic Resonance Imaging |
0.9% |
| Prophylaxis Against Transplant Rejection |
0.9% |
| Prophylaxis Against Graft Versus Host Disease |
0.9% |
|
| Vomiting |
12.5% |
| Renal Failure Acute |
10.1% |
| Renal Failure |
8.9% |
| Renal Impairment |
5.6% |
| Urinary Tract Infection |
5.2% |
| Sepsis |
5.1% |
| White Blood Cell Count Decreased |
4.9% |
| Pain |
4.8% |
| Injury |
4.7% |
| Death |
4.1% |
| Renal Failure Chronic |
4.1% |
| Weight Decreased |
4.1% |
| Fear |
3.5% |
| Pneumonia |
3.5% |
| Thrombocytopenia |
3.4% |
| Pyrexia |
3.2% |
| Respiratory Failure |
3.1% |
| Therapeutic Response Decreased |
3.1% |
| Unevaluable Event |
3.1% |
| Anaemia |
3.0% |
|
| Interacting |
| Non-hodgkin's Lymphoma |
42.1% |
| Infection |
21.1% |
| B-cell Lymphoma |
13.2% |
| Renal Failure Chronic |
13.2% |
| Herpes Simplex |
2.6% |
| Hyperlipidaemia |
2.6% |
| Hypothyroidism |
2.6% |
| Sarcoma |
2.6% |
|
| Toxicity To Various Agents |
57.1% |
| Dyspnoea |
14.3% |
| Transaminases Increased |
14.3% |
| Trichosporon Infection |
14.3% |
|
